Neuropsychological assessment after long-term omeprazole treatment

• Published in: Applied neuropsychology. Adult Vol. 31; no. 5; pp. 1007 - 1015
• Main Authors: Haefliger, Rochelli, Dries, Larissa Selbach, Perassolo, Magda Susana, Cardoso, Caroline de Oliveira
• Format: Journal Article
• Language: English
• Published: United States Routledge 02.09.2024
• Subjects: Adverse effects; cognitive impairment; neuropsychological assessment; omeprazole; proton pump inhibitors; proton pump inhibitors; neuropsychological assessment; omeprazole; cognitive impairment; Adverse effects
• ISSN: 2327-9095; 2327-9109; 2327-9109
• DOI: 10.1080/23279095.2022.2106570

Recent studies suggest that Omeprazole, a widely used treatment for gastric acid-related disorders, may have a significant effect on human cognition. However, there is no consensus on the matter. Though some studies suggest the drug is associated with an increased risk of cognitive decline, memory impairment, and dementia, this issue has not been sufficiently studied. Therefore, the goal of this study was to investigate the cognitive impairments associated with long-term Omeprazole treatment, with a focus on memory, attention, and executive functions. Additionally, we sought to verify whether the duration of treatment was associated with the magnitude of the associated cognitive impairments. The sample consisted of 30 participants of both genders treated with Omeprazole (experimental group) and 30 participants who did not use the drug (control group). The cognitive assessment battery: Verbal Fluency, Rey Auditory-Verbal Learning, Attention Assessment Battery, Five Digit Test, Hayling Test, and NEUPSILIN Subtest. The groups were compared using Student's T-tests, and the association between treatment duration and cognitive performance was examined using Pearson's coefficients. The results showed significant group differences in verbal fluency, short-term episodic memory, selective attention, and executive functions. The duration of Omeprazole treatment was also positively associated with the magnitude of cognitive impairment.